144 related articles for article (PubMed ID: 38629462)
1. Pharmacogenetics of aminoglycoside-related ototoxicity: a systematic review.
Gaafar D; Baxter N; Cranswick N; Christodoulou J; Gwee A
J Antimicrob Chemother; 2024 Jul; 79(7):1508-1528. PubMed ID: 38629462
[TBL] [Abstract][Full Text] [Related]
2. Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.
McDermott JH; Wolf J; Hoshitsuki K; Huddart R; Caudle KE; Whirl-Carrillo M; Steyger PS; Smith RJH; Cody N; Rodriguez-Antona C; Klein TE; Newman WG
Clin Pharmacol Ther; 2022 Feb; 111(2):366-372. PubMed ID: 34032273
[TBL] [Abstract][Full Text] [Related]
3. Clinical Pharmacogenomic MT-RNR1 Screening for Aminoglycoside-Induced Ototoxicity and the Post-Test Counseling Conundrum.
Rigobello R; Shaw J; Ilg D; Zimmerman R; Edelmann L; Kornreich R; Scott SA; Cody N
Clin Pharmacol Ther; 2023 Aug; 114(2):262-265. PubMed ID: 37314952
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetics of aminoglycoside ototoxicity: State of knowledge and practices - Recommendations of the Francophone Network of Pharmacogenetics (RNPGx)].
Lebreton L; Hennart B; Baklouti S; Trimouille A; Boyer JC; Becquemont L; Dhaenens CM; Picard N
Therapie; 2024 Jun; ():. PubMed ID: 38876950
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of mitochondrial mutations associated with aminoglycoside-induced deafness in ethnic Latvian population: the appraisal of the evidence.
Igumnova V; Veidemane L; Vīksna A; Capligina V; Zole E; Ranka R
J Hum Genet; 2019 Mar; 64(3):199-206. PubMed ID: 30523288
[TBL] [Abstract][Full Text] [Related]
6. Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care.
McDermott JH; Mahaveer A; James RA; Booth N; Turner M; Harvey KE; Miele G; Beaman GM; Stoddard DC; Tricker K; Corry RJ; Garlick J; Ainsworth S; Beevers T; Bruce IA; Body R; Ulph F; MacLeod R; Roberts PL; Wilson PM; Newman WG;
JAMA Pediatr; 2022 May; 176(5):486-492. PubMed ID: 35311942
[TBL] [Abstract][Full Text] [Related]
7. Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated?
Al-Malky G; Suri R; Sirimanna T; Dawson SJ
Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):969-73. PubMed ID: 24703164
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility to aminoglycoside ototoxicity.
Nguyen T; Jeyakumar A
Int J Pediatr Otorhinolaryngol; 2019 May; 120():15-19. PubMed ID: 30743189
[TBL] [Abstract][Full Text] [Related]
9. Detecting mitochondrial mutations associated with aminoglycoside ototoxicity by noninvasive prenatal testing.
Huang Q; Liu Y; Lei W; Liang J; Wang Y; Zheng M; Huang X; Liu Y; Huang K; Huang M
J Clin Lab Anal; 2023 Jan; 37(1):e24827. PubMed ID: 36579624
[TBL] [Abstract][Full Text] [Related]
10. Sensorineural hearing loss with macrolide antibiotics exposure: a meta-analysis of the association.
Alsowaida YS; Almulhim AS; Oh M; Erstad B; Abraham I
Int J Pharm Pract; 2021 Feb; 29(1):21-28. PubMed ID: 32871046
[TBL] [Abstract][Full Text] [Related]
11. Macrolide-associated sensorineural hearing loss: A systematic review.
Ikeda AK; Prince AA; Chen JX; Lieu JEC; Shin JJ
Laryngoscope; 2018 Jan; 128(1):228-236. PubMed ID: 28771738
[TBL] [Abstract][Full Text] [Related]
12. Allele-specific PCR for detecting the deafness-associated mitochondrial 12S rRNA mutations.
Ding Y; Xia BH; Liu Q; Li MY; Huang SX; Zhuo GC
Gene; 2016 Oct; 591(1):148-152. PubMed ID: 27397648
[TBL] [Abstract][Full Text] [Related]
13. The role of routine hearing screening in children with cystic fibrosis on aminoglycosides: A systematic review.
Farzal Z; Kou YF; St John R; Shah GB; Mitchell RB
Laryngoscope; 2016 Jan; 126(1):228-35. PubMed ID: 26152803
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial mutations in maternally inherited hearing loss.
Mutai H; Watabe T; Kosaki K; Ogawa K; Matsunaga T
BMC Med Genet; 2017 Mar; 18(1):32. PubMed ID: 28320335
[TBL] [Abstract][Full Text] [Related]
15. Frequency and spectrum of mitochondrial 12S rRNA variants in 440 Han Chinese hearing impaired pediatric subjects from two otology clinics.
Shen Z; Zheng J; Chen B; Peng G; Zhang T; Gong S; Zhu Y; Zhang C; Li R; Yang L; Zhou J; Cai T; Jin L; Lu J; Guan MX
J Transl Med; 2011 Jan; 9():4. PubMed ID: 21205314
[TBL] [Abstract][Full Text] [Related]
16. Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.
Hong H; Dooley KE; Starbird LE; Francis HW; Farley JE
Arch Toxicol; 2019 May; 93(5):1385-1399. PubMed ID: 30963202
[TBL] [Abstract][Full Text] [Related]
17. Maternally transmitted aminoglycoside-induced and non-syndromic hearing loss caused by the 1494C > T mutation in the mitochondrial 12S rRNA gene in two Chinese families.
Wei Q; Xu D; Chen Z; Li H; Lu Y; Liu C; Bu X; Xing G; Cao X
Int J Audiol; 2013 Feb; 52(2):98-103. PubMed ID: 23237192
[TBL] [Abstract][Full Text] [Related]
18. Extended-interval aminoglycoside administration for children: a meta-analysis.
Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
